Clinical trials recruiting in Chiyoda-ku, Japan

Phase breakdown

Conditions recruiting in Chiyoda-ku, Japan

Recruiting trials in Chiyoda-ku, Japan

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
  NCT07684235 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
  NCT07125417 · Phase: Phase 4 · Ages: No age limits stated · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Chiyoda-ku, Japan?

3 recruiting trials have at least one study site in Chiyoda-ku, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.